Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Karyopharm Therapeut (NQ: KPTI )

5.820 +0.170 (+3.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,125,838
Open 5.760
Bid (Size) 5.500 (1)
Ask (Size) 6.150 (12)
Prev. Close 5.650
Today's Range 5.550 - 5.990
52wk Range 4.420 - 12.44
Shares Outstanding 79,418,349
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analyst Ratings for Karyopharm Therapeutics
Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter: 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-18.03%
-18.03%
1 Month
-13.39%
-13.39%
3 Month
-43.44%
-43.44%
6 Month
-22.91%
-22.91%
1 Year
-37.22%
-37.22%

More News

Read More
Recap: Karyopharm Therapeutics Q1 Earnings
Via Benzinga
Karyopharm Therapeutics Earnings Preview
Via Benzinga
What 5 Analyst Ratings Have To Say About Karyopharm Therapeutics
Via Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Via Benzinga
Mid-Afternoon Market Update: Dow Gains 2%; SAB Biotherapeutics Shares Slide
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Mid-Day Market Update: Nasdaq Surges 150 Points; US Crude Oil Inventories Fall By 2.6M Barrels
Via Benzinga
Mid-Morning Market Update: U.S. Stocks Mixed; Dollar Tree Reports Mixed Q4 Results
Via Benzinga
Where Karyopharm Therapeutics Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
Via Benzinga
Why Are Karyopharm Shares Trading Lower Today
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
28 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
73 Biggest Movers From Yesterday
Via Benzinga
Why Are Karyopharm Shares Plunging Today?
Via Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
70 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.